About Planeeria

About company

Planeeria focuses on developing a product based on recombinant human amelogenin as an active ingredient for the treatment of injured cartilage and ligaments. The company develops innovative products for regeneration and recovery after injuries. Planeeria was founded in 2018 and is headquartered in